Invention Grant
- Patent Title: Use of hepcidin as a regulator of iron homeostasis
-
Application No.: US15672616Application Date: 2017-08-09
-
Publication No.: US10004784B2Publication Date: 2018-06-26
- Inventor: Gael Nicolas , Sophie Vaulont , Axel Kahn
- Applicant: Institut National de la Sante et de la Recherche Medicale
- Applicant Address: FR Paris
- Assignee: Institut National de la Sante et de la Recherche Medicale
- Current Assignee: Institut National de la Sante et de la Recherche Medicale
- Current Assignee Address: FR Paris
- Agency: Foley Hong LLP
- Agent David P. Halstead; Jack Rosa
- Priority: EP01401377 20010525; EP01401537 20010614; EP02290795 20020329
- Main IPC: A61K38/22
- IPC: A61K38/22 ; A61K38/17 ; G01N33/90 ; A61K38/10
Abstract:
The invention concerns the use of hepcidin for the diagnosis and therapy of disorders of iron homeostasis. Hepcidin can be used in the treatment of disorders resulting from iron overload while inhibitors of hepcidin can be used in the treatment of anaemia.
Public/Granted literature
- US20170340710A1 USE OF HEPCIDIN AS A REGULATOR OF IRON HOMEOSTASIS Public/Granted day:2017-11-30
Information query
IPC分类:
